Vestaron Closes Series C Funding at $82M
Retrieved on:
月曜日, 5月 16, 2022
RTP, North Carolina, May 16, 2022 (GLOBE NEWSWIRE) -- Vestaron, a leader in peptide-based biological crop protection, is pleased to announce the official closing of the Series C fundraising efforts at $82M as of May 12, 2022.
Key Points:
- RTP, North Carolina, May 16, 2022 (GLOBE NEWSWIRE) -- Vestaron, a leader in peptide-based biological crop protection, is pleased to announce the official closing of the Series C fundraising efforts at $82M as of May 12, 2022.
- Lead investors joining Vestaron in the peptide revolution include Ordway Selections and Cavallo Ventures.
- Kartik Dharmadhikari, Principal of Novo Holdings and Vestaron board member shares thoughts, Vestaron continues to outline and achieve milestones.
- With the recent fundraising, the Vestaron board will addAriel Barack(Ordway), Mike Wilbur (Cavallo) and Craig Herron (iSelect) as board observers.